Vir Biotechnology develops product candidates for serious infectious diseases and cancer. It last closed at $8.39 on Nov 20, down 5.41% on the day. The next earnings report for VIR is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, VIR reported EPS of -$0.57. Over its last 8 reports the stock moved an average of 9.0% the session after earnings. Over the last 12 months VIR insiders bought $0 of stock on the open market and sold $8.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is VIR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VIR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on VIRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
VIR · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 32% below its 20 day and 31% below its 50 day average. It is 17% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), oversold. The nearest support is the Pivot S1 at $8.18, and the nearest resistance the Pivot at $8.55.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 9.5%/day
Key levels
$14.3852 week high+71.4%
$11.1020 day average+32.3%
$10.9650 day average+30.6%
$10.38100 day average+23.7%
$9.80200 day average+16.8%
$9.70Swing high (Aug 6)+15.6%
$8.76Pivot R1+4.4%
$8.55Pivot+1.9%
$8.39Last close
$8.18Pivot S1−2.5%
$8.16Swing low (Jun 10)−2.7%
$5.4552 week low−35.0%
Indicators
RSI (14)
32.90
Weak, oversold below 30
Neutral
MACD
-0.52
Below its signal line
Bearish
Stochastic
1.1
Near the bottom of its range
Oversold
ADX (14)
23.9
Weak trend
Williams %R
-99.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-155.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−31.3%
Change over 10 sessions
Bearish
ATR (14)
$0.80
Typical daily range, 9.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 17.8%/day
Key levels
$14.3852 week high+71.4%
$11.1020 day average+32.3%
$10.9650 day average+30.6%
$10.38100 day average+23.7%
$9.80200 day average+16.8%
$9.70Swing high (Aug 6)+15.6%
$8.76Pivot R1+4.4%
$8.55Pivot+1.9%
$8.39Last close
$8.18Pivot S1−2.5%
$8.16Swing low (Jun 10)−2.7%
$5.4552 week low−35.0%
Indicators
RSI (14)
42.09
Middle of its range
Neutral
MACD
0.34
Below its signal line
Bearish
Stochastic
38.7
Middle of its range
Neutral
ADX (14)
36.5
Trending up
Williams %R
-99.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-107.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−21.0%
Change over 10 sessions
Bearish
ATR (14)
$1.49
Typical daily range, 17.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for VIR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VIR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow VIR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for VIRHow many large options trades hit VIR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in VIR in the last 90 days.
From SEC Form 4 filings by VIR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VIR is in one of them and how their past VIR trades turned out.
Vir Biotechnology is a biotechnology company based in San Francisco, California. It is developing product candidates, none yet approved, for serious infectious diseases and cancer, built on several technology platforms. The company also works with other drugmakers through collaboration and licensing agreements, both acquiring rights to some candidates and granting rights to others for further development.